DUBLIN, May 12, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Pharmacogenomics (PGx) Market Analysis: Focus on Ecosystem Players, Therapeutic Applications, and Geography - Estimation & Forecast 2016-2022" report to their offering.
Global Pharmacogenomics (PGx) Market Analysis: Focus on Ecosystem Players (Diagnostic Test, Pharmaceutical & Others), Therapeutic Applications (Oncology, Cardiovascular & Others)
Tthe global PGx market is expected to grow over $14.85 billion by 2022
Rapid advancement and innovation of new healthcare technologies such as next generation sequencing, High Throughput Screening (HTS), and Digital Polymerase Chain Reaction (PCR) are developing a strong base for the growth of Pharmacogenomics (PGx) market.
Diagnostic Test segment is holding the maximum market share and is expected to grow at 11.63% CAGR from 2016 to 2022. This is due to the increasing demand for diagnostic tests as patients are emphasizing more on pre-diagnosis treatments, increasing genetic disorders & mutational diseases, and government initiatives and investment in research and development programs among others.
Observing current trends, Big Data companies included in service provider segments are collaborating and entering into partnerships with healthcare providers, academic institutions, pharmaceuticals and biotechnology companies to support the growth of the PGx market and thus, service segment is anticipated to grow at a high CAGR of 16.22% from 2016 to 2022. Moreover, the Pharmaceutical segment will also gain from traction of the patients due to increasing awareness about the benefits of PGx solutions and adoption of these solutions in developing regions.
The report has been further classified on the basis of ecosystem players, therapeutic applications, and geographical regions. Ecosystem is further segmented into: Pharmaceuticals companies, Diagnostic Companies, and Service Providers, which include Software & Healthcare database providers, Hospitals & Care Providers, and Insurance Providers.
Key Topics Covered:
1. Report Overview
2. Executive Summary
3. Market Overview
4. Competitive Insights
5. Industry Analysis
6. Global Pharmacogenomics Market By Technology
7. Global Pharmacogenomics Market By Ecosystem Players
8. Global Pharmacogenomics Market By Therapeutic Applications
9. Global Pharmacogenomics Market By Geography
10. Company Overview
- Abbott Laboratories
- Affymetrix, Inc.
- Assurex Health, Inc.
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- Myriad Genetics, Inc.
- Pfizer, Inc.
- Qiagen, Inc.
- Roche Holding Ag-Br
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific
- Transgenomic, Inc.
For more information visit http://www.researchandmarkets.com/research/6qsc8q/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-pharmacogenomics-pgx-market-analysis-2016-2022-ecosystem-players-diagnostic-test-pharmaceutical--others--therapeutic-applications-oncology-cardiovascular--others---research-and-markets-300267922.html
SOURCE Research and Markets